Financials

  • Market Capitalization 805.76 M
  • Employee 294
  • Founded N/A
  • CEO Sheldon Koenig
  • Website www.esperion.com
  • Headquarter Delaware, United States
  • FIGI BBG004KB3S72
  • Industry İlaç Üreticileri - Özel ve Eşdeğer
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-33.64
Fiyat/satışlar oranı
1.91

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Haberler